Ý - Tiếng Ý - AIFA (Agenzia Italiana del Farmaco)

sandoz s.p.a. - ziprasidone - ziprasidone

Ý - Tiếng Ý - AIFA (Agenzia Italiana del Farmaco)

mylan s.p.a. - ziprasidone - ziprasidone

Ý - Tiếng Ý - AIFA (Agenzia Italiana del Farmaco)

teva italia s.r.l. - ziprasidone - ziprasidone

Ý - Tiếng Ý - AIFA (Agenzia Italiana del Farmaco)

viatris pharma s.r.l. - ziprasidone - ziprasidone

Ý - Tiếng Ý - AIFA (Agenzia Italiana del Farmaco)

pricetag spa - ziprasidone - ziprasidone

Ý - Tiếng Ý - AIFA (Agenzia Italiana del Farmaco)

general pharma solutions spa - ziprasidone - ziprasidone

Liên Minh Châu Âu - Tiếng Ý - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamide - neoplasie prostatiche - terapia endocrina - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Ý - Tiếng Ý - AIFA (Agenzia Italiana del Farmaco)

aurobindo pharma (italia) s.r.l. - ivabradina - ivabradina

Ý - Tiếng Ý - AIFA (Agenzia Italiana del Farmaco)

istituto luso farmaco d'italia s.p.a. - aloperidolo - aloperidolo

Ý - Tiếng Ý - AIFA (Agenzia Italiana del Farmaco)

hikma farmaceutica (portugal) s.a. - amantadina - amantadina